Catalyst
Slingshot members are tracking this event:
Pacira (PCRX) Expects Top-Line Data in Mid-2017 for Phase 3 Label Expansion Studies of EXPAREL in Brachial Plexus Nerve Block for Rotator Cuff/Shoulder Arthroplasty and Femoral Nerve Block for Total Knee Arthroplasty (TKA)
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| PCRX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 25, 2017
Occurred Source:
http://investor.pacira.com/phoenix.zhtml?c=220759&p=irol-newsArticle&ID=2288475
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Top-line Data, Phase 3, Label Expansion Study, Exparel, Brachial Plexus Nerve Block, Rotator Cuff Arthroplasty, Shoulder Arthroplasty, Femoral Nerve Block, Total Knee Arthroplasty, Tka
